{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:42:35Z","timestamp":1780512155045,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-024-01479-y","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:03:26Z","timestamp":1729785806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bioinformatic and experimental analyses of GATA3 and its regulatory miRNAs in breast Cancer"],"prefix":"10.1007","volume":"15","author":[{"given":"Fatemeh","family":"Roohy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Moghanibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"issue":"8","key":"1479_CR1","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.3390\/cancers12082296","volume":"12","author":"K Vishnoi","year":"2020","unstructured":"Vishnoi K, Viswakarma N, Rana A, Rana B. Transcription factors in cancer development and therapy. Cancers. 2020;12(8):2296.","journal-title":"Cancers"},{"issue":"11","key":"1479_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","volume":"19","author":"JH Bushweller","year":"2019","unstructured":"Bushweller JH. Targeting transcription factors in cancer\u2014from undruggable to reality. Nat Rev Cancer. 2019;19(11):611\u201324.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1479_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/iub.2169","volume":"72","author":"O Romano","year":"2020","unstructured":"Romano O, Miccio A. GATA factor transcriptional activity: insights from genome-wide binding profiles. IUBMB Life. 2020;72(1):10\u201326.","journal-title":"IUBMB Life"},{"key":"1479_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037487.","author":"DA Abunimye","year":"2024","unstructured":"Abunimye DA, Okafor IM, Okorowo H, Obeagu EI. The role of GATA family transcriptional factors in haematological malignancies: a review. Medicine. 2024. https:\/\/doi.org\/10.1097\/MD.0000000000037487.","journal-title":"Medicine"},{"issue":"1","key":"1479_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/jcp.21943","volume":"222","author":"J Chou","year":"2010","unstructured":"Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it. J Cell Physiol. 2010;222(1):42\u20139. https:\/\/doi.org\/10.1002\/jcp.21943.","journal-title":"J Cell Physiol"},{"key":"1479_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11040604","author":"P Querzoli","year":"2021","unstructured":"Querzoli P, Pedriali M, Rinaldi R, Secchiero P, Rossi PG, Kuhn E. GATA3 as an adjunct prognostic factor in breast cancer patients with less aggressive disease: a study with a review of the literature. Diagnostics. 2021. https:\/\/doi.org\/10.3390\/diagnostics11040604.","journal-title":"Diagnostics"},{"issue":"5","key":"1479_CR7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2006.09.048","volume":"127","author":"H Kouros-Mehr","year":"2006","unstructured":"Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate. Mammary Gland Cell. 2006;127(5):1041\u201355. https:\/\/doi.org\/10.1016\/j.cell.2006.09.048.","journal-title":"Mammary Gland Cell"},{"issue":"12","key":"1479_CR8","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1002\/dvdy.20978","volume":"235","author":"H Kouros-Mehr","year":"2006","unstructured":"Kouros-Mehr H, Werb Z. Candidate regulators of mammary branching morphogenesis identified by genome\u2010wide transcript analysis. Dev Dyn Official Publ Am Assoc Anatomists. 2006;235(12):3404\u201312. https:\/\/doi.org\/10.1002\/dvdy.20978.","journal-title":"Dev Dyn Official Publ Am Assoc Anatomists"},{"key":"1479_CR9","doi-asserted-by":"publisher","first-page":"153611","DOI":"10.1016\/j.prp.2021.153611","volume":"226","author":"MK Najafabadi","year":"2021","unstructured":"Najafabadi MK, Mirzaeian E, Montazerin SM, Tavangar AR, Tabary M, Tavangar SM. Role of GATA3 in tumor diagnosis: a review. Pathol Res Pract. 2021;226:153611. https:\/\/doi.org\/10.1016\/j.prp.2021.153611.","journal-title":"Pathol Res Pract"},{"issue":"6127","key":"1479_CR10","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546\u201358. https:\/\/doi.org\/10.1126\/science.1235122.","journal-title":"Science"},{"issue":"4","key":"1479_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3727\/105221615X14399878166113","volume":"16","author":"M Takaku","year":"2015","unstructured":"Takaku M, Grimm SA, Wade PA. GATA3 in breast cancer: tumor suppressor or oncogene? Gene Expr. 2015;16(4):163. https:\/\/doi.org\/10.3727\/105221615X14399878166113.","journal-title":"Gene Expr"},{"issue":"5","key":"1479_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ccr.2009.03.004","volume":"15","author":"XH Pei","year":"2009","unstructured":"Pei XH, Bai F, Smith MD, Usary J, Fan C, Pai SY, Xiong Y. CDK inhibitor p18INK4c is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell. 2009;15(5):389\u2013401. https:\/\/doi.org\/10.1016\/j.ccr.2009.03.004.","journal-title":"Cancer Cell"},{"issue":"8","key":"1479_CR13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/cells8080840","volume":"8","author":"AQ Khan","year":"2019","unstructured":"Khan AQ, Ahmed EI, Elareer NR, Junejo K, Steinhoff M, Uddin S. Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies. Cells. 2019;8(8):840. https:\/\/doi.org\/10.3390\/cells8080840.","journal-title":"Cells"},{"issue":"4","key":"1479_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.tig.2021.10.002","volume":"38","author":"MP Dragomir","year":"2022","unstructured":"Dragomir MP, Knutsen E, Calin GA. Classical and noncanonical functions of miRNAs in cancers. Trends Genet. 2022;38(4):379\u201394. https:\/\/doi.org\/10.1016\/j.tig.2021.10.002.","journal-title":"Trends Genet"},{"key":"1479_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188413","author":"A Kandettu","year":"2020","unstructured":"Kandettu A, Radhakrishnan R, Chakrabarty S, Sriharikrishnaa S, Kabekkodu SP. The emerging role of miRNA clusters in breast cancer progression. Biochimica Et Biophys Acta BBA Rev Cancer. 2020. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188413.","journal-title":"Biochimica Et Biophys Acta BBA Rev Cancer"},{"issue":"6","key":"1479_CR16","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1002\/jcp.29396","volume":"235","author":"M Abolghasemi","year":"2020","unstructured":"Abolghasemi M, Tehrani SS, Yousefi T, Karimian A, Mahmoodpoor A, Ghamari A, Rameshknia V. MicroRNAs in breast cancer: roles, functions, and mechanism of actions. J Cell Physiol. 2020;235(6):5008\u201329. https:\/\/doi.org\/10.1002\/jcp.29396.","journal-title":"J Cell Physiol"},{"issue":"4","key":"1479_CR17","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s11011-022-00922-9","volume":"37","author":"M Ghorbani","year":"2022","unstructured":"Ghorbani M, Mohamadynejad P, Moghanibashi M. Significant association of rs77493513 polymorphism in 3\u2019-UTR of the NRG1 gene with the risk of multiple sclerosis disease. Metab Brain Dis. 2022;37(4):1025\u201330. https:\/\/doi.org\/10.1007\/s11011-022-00922-9.","journal-title":"Metab Brain Dis"},{"issue":"11","key":"1479_CR18","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.3390\/cancers12113271","volume":"12","author":"M Baliu-Piqu\u00e9","year":"2020","unstructured":"Baliu-Piqu\u00e9 M, Pandiella A, Ocana A. Breast cancer heterogeneity and response to novel therapeutics. Cancers. 2020;12(11):3271. https:\/\/doi.org\/10.3390\/cancers12113271.","journal-title":"Cancers"},{"issue":"11","key":"1479_CR19","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/ijc.29923","volume":"138","author":"K Banerjee","year":"2016","unstructured":"Banerjee K, Resat H. Constitutive activation of STAT 3 in breast cancer cells: a review. Int J Cancer. 2016;138(11):2570\u20138.","journal-title":"Int J Cancer"},{"issue":"1","key":"1479_CR20","doi-asserted-by":"publisher","first-page":"8796","DOI":"10.1038\/srep08796","volume":"5","author":"Y Liu","year":"2015","unstructured":"Liu Y, Ao X, Jia Z, Bai XY, Xu Z, Hu G, Wu H. FOXK2 transcription factor suppresses ER\u03b1-positive breast cancer cell growth through down-regulating the stability of ER\u03b1 via mechanism involving BRCA1\/BARD1. Sci Rep. 2015;5(1):8796.","journal-title":"Sci Rep"},{"issue":"4","key":"1479_CR21","doi-asserted-by":"publisher","first-page":"pbad028","DOI":"10.1093\/pcmedi\/pbad028","volume":"6","author":"A Amarah","year":"2023","unstructured":"Amarah A, Elsabagh AA, Ouda A, Karen O, Ferih K, Elmakaty I, Malki MI. Emerging roles of activating transcription factor 2 in the development of breast cancer: a comprehensive review. Precis Clin Med. 2023;6(4):pbad028.","journal-title":"Precis Clin Med"},{"issue":"6","key":"1479_CR22","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2174\/2210298101666210914091839","volume":"1","author":"J Yang","year":"2021","unstructured":"Yang J, Zhao X, Huang R, Zhao J, Guo M, Zhou Y, Xu L. The role of GATA3 in breast cancer: an updated review. Curr Chin Sci. 2021;1(6):608\u201315.","journal-title":"Curr Chin Sci"},{"key":"1479_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.humpath.2015.09.035","volume":"48","author":"R Asch-Kendrick","year":"2016","unstructured":"Asch-Kendrick R, Cimino-Mathews A. The role of GATA3 in breast carcinomas: a review. Hum Pathol. 2016;48:37\u201347. https:\/\/doi.org\/10.1016\/j.humpath.2015.09.035.","journal-title":"Hum Pathol"},{"issue":"7418","key":"1479_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"JP Peter","year":"2012","unstructured":"Peter JP, Kucherlapati R, Chad JC, Lawrence AD, Mark SRSG, Heidi JS, Jacqueline DP. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","journal-title":"Nature"},{"key":"1479_CR25","doi-asserted-by":"publisher","first-page":"820532","DOI":"10.3389\/fgene.2022.820532","volume":"13","author":"M Saotome","year":"2022","unstructured":"Saotome M, Poduval DB, Nair R, Cooper M, Takaku M. GATA3 truncation mutants alter EMT related gene expression via partial motif recognition in luminal breast cancer cells. Front Genet. 2022;13:820532.","journal-title":"Front Genet"},{"issue":"8","key":"1479_CR26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1210\/me.2009-0062","volume":"23","author":"BD Adams","year":"2009","unstructured":"Adams BD, Cowee DM, White BA. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-\u03b1 (ER\u03b1) signaling and a luminal phenotype in MCF-7 breast cancer cells. Mol Endocrinol. 2009;23(8):1215\u201330.","journal-title":"Mol Endocrinol"},{"issue":"9","key":"1479_CR27","first-page":"779","volume":"37","author":"H Han","year":"2022","unstructured":"Han H, Xu X. MiR-205 promotes the viability, migration, and tube formation of cervical cancer cells in vitro by targeting GATA3. Cancer Biother Radiopharm. 2022;37(9):779\u201391.","journal-title":"Cancer Biother Radiopharm"},{"key":"1479_CR28","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2018_180830N659","author":"J Gao","year":"2019","unstructured":"Gao J, Bai S, Wang Y, Zhao S, He Z, Wang R. MiR-374b targets GATA3 to promote progression and development of glioblastoma via regulating SEMA3B. Neoplasma. 2019. https:\/\/doi.org\/10.4149\/neo_2018_180830N659.","journal-title":"Neoplasma"},{"key":"1479_CR29","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20200626","author":"SQ Liu","year":"2020","unstructured":"Liu SQ, Zhou ZY, Dong X, Guo L, Zhang KJ. LncRNA GNAS-AS1 facilitates ER + breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p\/GATA3 axis. Biosci Rep. 2020. https:\/\/doi.org\/10.1042\/BSR20200626.","journal-title":"Biosci Rep"},{"key":"1479_CR30","doi-asserted-by":"publisher","first-page":"144411","DOI":"10.1016\/j.gene.2020.144411","volume":"737","author":"P Yao","year":"2020","unstructured":"Yao P, Li YL, Chen Y, Shen W, Wu KY, Xu WH. Overexpression of long non-coding RNA Rian attenuates cell apoptosis from cerebral ischemia-reperfusion injury via Rian\/miR-144-3p\/GATA3 signaling. Gene. 2020;737:144411. https:\/\/doi.org\/10.1016\/j.gene.2020.144411.","journal-title":"Gene"},{"issue":"29","key":"1479_CR31","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1038\/onc.2009.126","volume":"28","author":"AB Dydensborg","year":"2009","unstructured":"Dydensborg AB, Rose AAN, Wilson BJ, Grote D, Paquet M, Giguere V, Bouchard M. GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene. 2009;28(29):2634\u201342. https:\/\/doi.org\/10.1038\/onc.2009.126.","journal-title":"Oncogene"},{"issue":"18","key":"1479_CR32","doi-asserted-by":"publisher","first-page":"14042","DOI":"10.1074\/jbc.M110.105262","volume":"285","author":"W Yan","year":"2010","unstructured":"Yan W, Cao QJ, Arenas RB, Bentley B, Shao R. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem. 2010;285(18):14042\u201351. https:\/\/doi.org\/10.1074\/jbc.M110.105262.","journal-title":"J Biol Chem"},{"issue":"2","key":"1479_CR33","doi-asserted-by":"publisher","first-page":"e1955","DOI":"10.1002\/cnr2.1955","volume":"7","author":"MY Farsani","year":"2024","unstructured":"Farsani MY, Amini Farsani Z, Teimuri S, Kolahdouzan M, Samani RE, Teimori H. Deregulation of miR-1245b-5p and miR-92a-3p and their potential target gene, GATA3, in epithelial\u2013mesenchymal transition pathway in breast cancer. Cancer Rep. 2024;7(2):e1955.","journal-title":"Cancer Rep"},{"key":"1479_CR34","doi-asserted-by":"crossref","unstructured":"Zhong Y, Yi C. MicroRNA-720 suppresses M2 macrophage polarization by targeting GATA3. Biosci Rep. 2016;36(4):e00363.","DOI":"10.1042\/BSR20160105"},{"issue":"4","key":"1479_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/15384047.2017.1416934","volume":"19","author":"Y Yin","year":"2018","unstructured":"Yin Y, Cai J, Meng F, Sui C, Jiang Y. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55. Cancer Biol Ther. 2018;19(4):306\u201315. https:\/\/doi.org\/10.1080\/15384047.2017.1416934.","journal-title":"Cancer Biol Ther"},{"key":"1479_CR36","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S103650","author":"Y Pan","year":"2016","unstructured":"Pan Y, Zhang J, Fu H, Shen L. miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1\/2-mediated epithelial mesenchymal transition process. Onco Target Ther. 2016. https:\/\/doi.org\/10.2147\/OTT.S103650.","journal-title":"Onco Target Ther"},{"issue":"6","key":"1479_CR37","doi-asserted-by":"publisher","first-page":"622","DOI":"10.7150\/ijbs.24223","volume":"14","author":"T Zhang","year":"2018","unstructured":"Zhang T, Jiang K, Zhu X, Zhao G, Wu H, Deng G, Qiu C. miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a. Int J Biol Sci. 2018;14(6):622. https:\/\/doi.org\/10.7150\/ijbs.24223.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1479_CR38","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41467-018-03478-4","volume":"9","author":"M Takaku","year":"2018","unstructured":"Takaku M, Grimm SA, Roberts JD, Chrysovergis K, Bennett BD, Myers P, Wade PA. GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network. Nut Commun. 2018;9(1):1059.","journal-title":"Nut Commun"},{"key":"1479_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0897-0","volume":"17","author":"M Takaku","year":"2016","unstructured":"Takaku M, Grimm SA, Shimbo T, Perera L, Menafra R, Stunnenberg HG, Wade PA. GATA3-dependent cellular reprogramming requires activation-domain dependent recruitment of a chromatin remodeler. Genom Biol. 2016;17:1\u201316.","journal-title":"Genom Biol"},{"key":"1479_CR40","doi-asserted-by":"publisher","unstructured":"DiDonna SC, Nagornyuk A, Adhikari N, Takada M, Takaku M. P4HTM: a novel downstream target of GATA3 in breast cancer. Res Square. 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-2622989\/v1.","DOI":"10.21203\/rs.3.rs-2622989\/v1"},{"issue":"2","key":"1479_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.healun.2021.10.004","volume":"41","author":"L P\u00e9rez-Carrillo","year":"2022","unstructured":"P\u00e9rez-Carrillo L, S\u00e1nchez-L\u00e1zaro I, Trivi\u00f1o JC, Feij\u00f3o-Band\u00edn S, Lago F, Gonz\u00e1lez-Juanatey JR, Rosell\u00f3-Llet\u00ed E. Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients. J Heart Lung Transplant. 2022;41(2):137\u201347.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"1479_CR42","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.3892\/ol.2020.11827","volume":"20","author":"J Xue","year":"2020","unstructured":"Xue J, Zhu X, Huang P, He Y, Xiao Y, Liu R, Zhao M. Expression of mir-129-5p and miR-433 in the serum of breast cancer patients and their relationship with clinicopathological features. Oncol Lett. 2020;20(3):2771\u20138.","journal-title":"Oncol Lett"},{"issue":"1","key":"1479_CR43","doi-asserted-by":"publisher","first-page":"17795","DOI":"10.1038\/s41598-024-68788-8","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen X, Zhao W, Huang Y, Luo S, Tang X, Yi Q. Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration. Sci Rep. 2024;14(1):17795.","journal-title":"Sci Rep"},{"issue":"11","key":"1479_CR44","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1038\/s41380-022-01712-6","volume":"27","author":"YY van der Zee","year":"2022","unstructured":"van der Zee YY, Eijssen LM, Mews P, Ramakrishnan A, Alvarez K, Lardner CK, Issler O. Blood miR-144-3p: a novel diagnostic and therapeutic tool for depression. Mol Psychiatry. 2022;27(11):4536\u201349.","journal-title":"Mol Psychiatry"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01479-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-024-01479-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01479-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:11:28Z","timestamp":1729786288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-024-01479-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1479"],"URL":"https:\/\/doi.org\/10.1007\/s12672-024-01479-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->\u00a0Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"588"}}